Viatris (VTRS) Competitors

Viatris (NASDAQ:VTRS) and argenx (NASDAQ:ARGX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Do analysts recommend VTRS or ARGX?

Viatris presently has a consensus target price of $10.50, suggesting a potential upside of 39.26%. argenx has a consensus target price of $690.33, suggesting a potential upside of 18.83%. Given Viatris' higher probable upside, equities analysts clearly believe Viatris is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91

Which has more volatility and risk, VTRS or ARGX?

Viatris has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.

Is VTRS or ARGX more profitable?

argenx has a net margin of -2.11% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-5.87%	16.46%	7.09%
argenx	-2.11%	-1.45%	-1.29%

Does the media favor VTRS or ARGX?

In the previous week, Viatris had 15 more articles in the media than argenx. MarketBeat recorded 51 mentions for Viatris and 36 mentions for argenx. argenx's average media sentiment score of 0.97 beat Viatris' score of -0.05 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	2 Very Positive mention(s)	5 Positive mention(s)	31 Neutral mention(s)	5 Negative mention(s)	7 Very Negative mention(s)	Neutral
argenx	18 Very Positive mention(s)	3 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, VTRS or ARGX?

Viatris has higher revenue and earnings than argenx. Viatris is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.74B	0.61	$54.70M	-$0.53	-14.23
argenx	$2.19B	16.12	-$295.05M	$12.59	46.14

Do insiders and institutionals hold more shares of VTRS or ARGX?

79.9% of Viatris shares are owned by institutional investors. Comparatively, 60.3% of argenx shares are owned by institutional investors. 0.1% of Viatris shares are owned by company insiders. Comparatively, 2.4% of argenx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in VTRS or ARGX?

argenx received 633 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 67.35% of users gave argenx an outperform vote while only 34.85% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
Viatris	Outperform Votes 23 34.85%	Underperform Votes 43 65.15%
argenx	Outperform Votes 656 67.35%	Underperform Votes 318 32.65%

Summary

argenx beats Viatris on 10 of the 19 factors compared between the two stocks.